MMK-1 [5256]



MMK-1


SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)O)C(C)C
InChIKey PWBQRCXCXXGUGY-AJOXZCOLSA-N
Sequence LESIFRSLLFRVM
HELM PEPTIDE1{L.E.S.I.F.R.S.L.L.F.R.V.M}$$$$

Chemical Properties

Hydrogen bond acceptors 20
Hydrogen bond donors 21
Rotatable bonds 54
Log P -2.749
Molecular weight (Da) 1609.9
Stereochemistry info partial

Database connections

Model (AF2) FPR2/ALX


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

MMK-1


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) FPR2/ALX


Compound is not listed as a drug.